Literature DB >> 21193113

Inflammation and coagulation. An overview.

Jari Petäjä1.   

Abstract

Inflammation and coagulation are two main host-defence systems that interact with each other. Inflammation activates coagulation and coagulation modulates the inflammatory activity in many ways. The contributing molecular pathways are reviewed. Thrombin and activated protein C (APC) and its receptor EPCR constitute a major physiological regulatory system to control vascular wall permeability during sepsis. Pro-inflammatory cellular effects of coagulation proteases as well as the anti-inflammatory effects of APC/EPCR are mediated by signaling via protease activated receptors PAR on mononuclear cells, endothelial cells, platelets, fibroblast, and smooth muscle cells. The beneficial effects of APC in sepsis are mainly dependent on the PAR-mediated cell-protective properties rather than the anticoagulant protease function on coagulation cofactors FV/Va and FVIII/VIIIa. Animal experiments with signaling selective APC-variants show promise in improving the therapeutic efficacy and safety of APC in sepsis. Copyright Â
© 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21193113     DOI: 10.1016/S0049-3848(10)70153-5

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  48 in total

1.  Isolated GHD: investigation and implication of JAK/STAT related genes before and after rhGH treatment.

Authors:  Letizia Trovato; Stefania Riccomagno; Flavia Prodam; Giulia Genoni; Gillian E Walker; Stefania Moia; Simonetta Bellone; Gianni Bona
Journal:  Pituitary       Date:  2012-12       Impact factor: 4.107

2.  Exogenous thrombin delivery promotes collateral capillary arterialization and tissue reperfusion in the murine spinotrapezius muscle ischemia model.

Authors:  Anthony C Bruce; Shayn M Peirce
Journal:  Microcirculation       Date:  2012-02       Impact factor: 2.628

3.  Proteomic analysis of differential protein expression in platelets of septic patients.

Authors:  Ji Liu; Jinbao Li; Xiaoming Deng
Journal:  Mol Biol Rep       Date:  2014-02-22       Impact factor: 2.316

4.  Platelet glycoprotein Ib-IX as a regulator of systemic inflammation.

Authors:  Adam Corken; Susan Russell; Judith Dent; Steven R Post; Jerry Ware
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-02-06       Impact factor: 8.311

5.  Contribution of endothelial cell and macrophage activation in the alterations induced by the venom of Micrurus tener tener in C57BL/6 mice.

Authors:  Emelyn Salazar; Ana María Salazar; Peter Taylor; Izaskun Urdanibia; Karin Pérez; Alexis Rodríguez-Acosta; Elda E Sánchez; Belsy Guerrero
Journal:  Mol Immunol       Date:  2019-10-07       Impact factor: 4.407

Review 6.  Coagulation and the fibrin network in rheumatic disease: a role beyond haemostasis.

Authors:  Berthold Hoppe; Thomas Dörner
Journal:  Nat Rev Rheumatol       Date:  2012-11-13       Impact factor: 20.543

7.  Intravenous Immunoglobulin Responsive Persistent Thrombocytopenia after Dengue Haemorrhagic Fever.

Authors:  Prabhat Kumar; Riyaz Charaniya; Anindya Ghosh; Ratnakar Sahoo
Journal:  J Clin Diagn Res       Date:  2016-04-01

8.  Conservation of the Host-Interacting Proteins Tp0750 and Pallilysin among Treponemes and Restriction of Proteolytic Capacity to Treponema pallidum.

Authors:  Simon Houston; John S Taylor; Yavor Denchev; Rebecca Hof; Richard L Zuerner; Caroline E Cameron
Journal:  Infect Immun       Date:  2015-08-17       Impact factor: 3.441

9.  Prehospital use of nonsteroidal anti-inflammatory drugs (NSAIDs) is associated with a reduced incidence of trauma-induced coagulopathy.

Authors:  Matthew D Neal; Joshua B Brown; Ernest E Moore; Joseph Cuschieri; Ronald V Maier; Joseph P Minei; Timothy R Billiar; Andrew B Peitzman; Mitchell J Cohen; Jason L Sperry
Journal:  Ann Surg       Date:  2014-08       Impact factor: 12.969

10.  Activation and proteolytic activity of the Treponema pallidum metalloprotease, pallilysin.

Authors:  Simon Houston; Rebecca Hof; Lisa Honeyman; Julia Hassler; Caroline E Cameron
Journal:  PLoS Pathog       Date:  2012-07-26       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.